Some patients with type 2 diabetes will be able to switch from daily insulin injections to this first-of-its-kind once-weekly ...
New program delivers family-centered diabetes education, clinical guidance, and device support for pediatric patients ...
Eli Lilly and Company report top-line phase 3 clinical trial results for its investigational GLP-1, GIP, and glucagon agonist ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results